Mary Cressell v. HHS - Pneumococcal, congestive heart failure, tachycardia, acute pericarditis, and chronic fatigue (2022)
Case summary [AI summaries can sometimes make mistakes]
Mary Cressell filed a petition on February 22, 2019, alleging that a pneumococcal conjugate (Prevnar 13) vaccine administered on February 25, 2016, caused her to develop congestive heart failure, tachycardia, acute pericarditis, and chronic fatigue. The respondent denied that the vaccine caused any of Petitioner's injuries or her current condition.
On August 3, 2022, the parties filed a stipulation recommending an award of compensation. Special Master Nora Beth Dorsey found the stipulation reasonable and adopted it as the decision of the Court.
Petitioner was awarded a lump sum of $46,277.14, payable to Petitioner, as compensation for all damages. The public decision does not describe the onset of symptoms, specific clinical details, or any expert testimony.
Petitioner was represented by Brian L. Cinelli of Schiffmacher Cinelli Adoff LLP, and Respondent was represented by Emilie Williams of the U.S.
Department of Justice.
Theory of causation
Petitioner alleged that a pneumococcal conjugate (Prevnar 13) vaccine administered on February 25, 2016, caused congestive heart failure, tachycardia, acute pericarditis, and chronic fatigue. Respondent denied causation. The parties reached a stipulation for compensation. The public decision does not detail the specific theory of causation, mechanism of injury, expert testimony, or clinical findings. Petitioner was awarded $46,277.14 as a lump sum. Special Master Nora Beth Dorsey issued the decision based on the stipulation on August 3, 2022. Petitioner's counsel was Brian L. Cinelli, and Respondent's counsel was Emilie Williams.
Source PDFs
USCOURTS-cofc-1_19-vv-00286